Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...

The maker of Ozempic and the weight loss drug Wegovy told the FDA on April 3 that counterfeit 1-milligram injections were ...

For decades, the medical approach to treating obesity in children was the wait-and-see approach. But a new Canadian guideline ...

The India launch of Eli Lilly's popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...

The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

The drugmaker said it would stop studying danuglipron after a participant had a possible drug-induced liver injury.

Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...

Eli Lilly's Mounjaro enters Indian market, triggering a sharp rise in consultations as obesity rates climb and patients seek more accessible treatment options ...

During a recent finance committee meeting, Deputy Comptroller Delano Dowell confirmed to the Common Council that so far in fiscal year 2024-2025, Buffalo has incumbered $2.1 million of unexpected ...

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...